EGFR and glioma: NIR fluorescence microscopy revealed specific cellular distribution of panitumumab-IRDye800 correlated with highly proliferative tumor cells (Ki-67) and positive EGFR expression in histologically confirmed (by H&E staining) viable tumor core and infiltrative tumor margin of high-grade gliomas (Figure 4D).